Head and Neck Cancer Therapeutics: Global Markets

Sep 2022| PHM264A| BCC Publishing

Report Highlights

The global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.

Report Includes

  • 64 data tables and 17 additional tables
  • A comprehensive overview of the global markets for head and neck cancer therapeutics within the industry
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation and forecast the actual market size for head and neck cancer therapeutics, and corresponding market share analysis by diagnostic method, treatment type, disease indication, route of administration, therapeutic class, end-user, and region
  • Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on COVID-19 impact on the head and neck cancer therapeutics market
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on new products development, regulatory scenario, and reimbursement and pricing factors
  • In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, and major types of end-user markets
  • Market share analysis of the key market participants in the global pharmaceuticals industry, their research priorities, product portfolios, pipeline products, and company competitive landscape
  • Descriptive company profiles of the leading global players, including AstraZeneca plc, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi S.A., Merck & Co., and Pfizer Inc.

Report Scope

This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding head and neck cancer therapeutic drugs.

An in-depth analysis of the global head and neck cancer therapeutics market includes historical data and market projections on sales by type of diagnostic method, treatment type, disease indication, route of administration, therapeutic class, and end user. It describes the different types of head and neck cancers (lip and oral cavity cancer, laryngeal cancer, oropharyngeal cancer, salivary gland cancer, nasopharyngeal cancer, and hypopharyngeal cancer) and their current and historical market revenues. This report also categorizes the global head and neck cancer therapeutics market based on the route of administration (injectable and oral).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares. The report also discusses pipeline analysis and the new regulatory landscape of the drugs marketed.

Frequently Asked Questions (FAQs)

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $1.6 billion
Market size forecast $2.5 billion
Growth rate CAGR of 8.5% from 2022 to 2027
Units considered $ Millions
Segments covered Diagnostic Method, Treatment Type, Disease Indication, Route of Administration, Therapeutic Class, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered United States, Canada, Germany, France, U.K., Spain, Italy, Sweden, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, India, Australia, South Korea, Singapore, New Zealand, Taiwan, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Immunotherapy against Autoimmune Disorders
  • Rising Incidence of Cancer Worldwide
  • Advances in Biochemistry and Genomics
  • High Unmet Need
Companies studied
  • ABBVIE INC.
  • ASTRAZENECA
  • BAYER AG
  • BRISTOL-MYERS SQUIBB CO.
  • ELI LILLY AND CO.
  • F. HOFFMANN-LA ROCHE LTD.
  • PFIZER INC.
  • MERCK & CO. INC.
  • SANOFI-AVENTIS

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Head and Neck Cancer Therapeutics: Global Markets148Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background13Free
Chapter- 4: Regulatory Structure5Free
Chapter- 5: Market Breakdown, by Diagnostic Method16Free
Chapter- 6: Market Breakdown, by Treatment Type20Free
Chapter- 7: Market Breakdown, by Disease Indication21Free
Chapter- 8: Market Breakdown, by Route of Administration9Free
Chapter- 9: Market Breakdown, by Therapeutic Class11Free
Chapter- 10: Market Breakdown, by End User14Free
Chapter- 11: Market Dynamics4Free
Chapter- 12: Impact of COVID-19 on the Market1Free
Chapter- 13: Pipeline Analysis1Free
Chapter- 14: Competitive Landscape1Free
Chapter- 15: Company Profiles20Free
Head and Neck Cancer Therapeutics: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS